Highest-materiality recent filing
Scientific Industries replaces auditor after BPB acquired by CRI
Audit committee dismissed BPB and appointed CRI as independent auditor on Jan 14, 2026, due to CRI's acquisition of BPB's capital markets practice.
Scientific Industries sells Genie Division for $9.6M; pro forma shows net gain
Sold Genie Division to Troemner LLC for $9.6M base plus up to $1.5M earn-out; $7.6M cash received.
Dismissed Forvis Mazars, LLP as auditor on August 22, 2025; no disagreements or reportable events.
Scientific Industries sells Genie Division for $9.6M plus up to $1.5M earn-out
Sold substantially all Genie Division assets (benchtop lab equipment) to Troemner, LLC for $9.6M base plus up to $1.5M earn-out.
Scientific Industries CFO departs; CEO Santos named interim CFO; contracts extended
CFO Nicholas Lavacca left May 19, 2025; CEO Helena Santos appointed interim CFO.
Scientific Industries raises $1.55M through private placement of 1.55M units
Sold 1,550,000 units at $1.00 each for total gross proceeds of $1,550,000.
Scientific Industries appoints Nicholas Lavacca CFO, replacing Reginald Averilla
Nicholas Lavacca named CFO effective April 1, 2025; Reginald Averilla left to pursue other opportunities.
Scientific Industries appoints Forvis Mazars as new auditor after Mazars USA merges into FORVIS
Mazars USA resigned effective June 1, 2024 as part of its combination with FORVIS, LLP.
Scientific Industries appoints Michael Blechman as Class B Director and committee chair
Michael Blechman appointed Class B Director, effective April 12, 2024.
Director Marcus Frampton resigns from Scientific Industries Board effective April 4, 2024
Marcus Frampton resigned as Class B Director by mutual agreement.
Scientific Industries appoints John Nicols as Class C Director and SBI Chairman
John Nicols appointed Class C Director, effective March 4, 2024.
Scientific Industries completes $7M private placement, issues shares and warrants
Final closing of private placement: sold 358,388 Units for $716,776; total offering 3.5M Units for $7M.
Scientific Industries raises $1.0M in private placement of common stock and warrants
Sold 503,536 Units (common stock and warrants) on Dec 19-20, 2023 for total consideration of $1,007,072.
Scientific Industries closes $5.28M private placement; issues units at $2.00 with warrants at $2.50
Sold 2,638,076 Units at $2.00 each for total proceeds of $5,276,152 in initial closing on Dec 13, 2023.
Scientific Industries increases authorized common shares from 20M to 30M
Increased authorized common shares from 20,000,000 to 30,000,000, par value $0.05 per share.
Scientific Industries dismisses MGO as auditor, appoints Mazars USA LLP; no disagreements reported
Dismissed Macias Gini & O'Connell LLP (MGO) as independent auditor on Nov 29, 2023.
Scientific Industries furnishes investor presentation with no specific financial details disclosed
Investor presentation furnished as Exhibit 99.1 will be used at upcoming investor meetings.
Scientific Industries enters employment agreement with CFO Reginald Averilla through June 2025
CFO Reginald Averilla employment agreement effective July 1, 2023 through June 30, 2025.
Scientific Industries board member Joseph Cremonese retires effective June 13, 2023
Joseph G. Cremonese resigned from the board of directors, effective June 13, 2023.
Non-reliance on FY2022 audited and Q1 FY2023 unaudited financials due to material misstatements.
Scientific Industries appoints MGO as new independent auditor effective December 19, 2022
Engaged Macias Gini & O'Connell LLP (MGO) as independent registered public accounting firm for fiscal period beginning July 1, 2022.
Scientific Industries' auditor resigns after combining with MGO; no prior disagreements
Nussbaum Berg Klein & Wolpow resigned as auditor on Nov 28, 2022 due to its merger with Macias Gini & O'Connell.
Scientific Industries changes fiscal year end from June 30 to December 31
Board approved change on Nov 4, 2022; fiscal year will end Dec 31.
Scientific Industries extends CEO and President employment contracts through June 2025
CEO Helena Santos' employment extended to June 30, 2025; all other terms unchanged.
Scientific Industries raises subsidiary CEO Grunes' base salary to €170k, extends notice
Base salary increased by €20k to €170k per year.
Scientific Industries names Reginald Averilla as CFO, replacing Helena R. Santos
Appointment effective April 11, 2022; Averilla brings over 10 years of financial and accounting experience.
Scientific Industries announces leadership changes: Vogt resigns, Moore and Gruenes appointed
Consulting agreement with Reinhard Vogt terminated effective April 1, 2022; notice period waived with single payment.
Scientific Industries raises $3M via PIPE; sells 549,456 shares + warrants at $5.50/share
Sold 549,456 shares of common stock and warrants for 274,727 additional shares at $5.50/share, gross proceeds $3,000,008.
Scientific Industries stockholders approve 5M share increase and 2022 Equity Incentive Plan
Stockholders approved amendment to increase authorized common stock from 15M to 20M shares.
Scientific Industries increases director Vogt's consulting retainer to €17,500/month
Effective February 1, 2022, the Company entered a second amendment to consulting agreement with director Reinhard Vogt.
Scientific Industries recovers $10,980 in Section 16(b) short-swing profits
Received $10,979.50 on December 9, 2021 as recovery of short-swing profits.
Scientific Industries provides pro forma financials for $7.9M aquila biolabs acquisition
Total consideration of €6.5M ($7.9M) for all outstanding shares of aquila biolabs GmbH, a German bioprocessing company.
On May 20, 2025, the Company announced the appointment of Ms. Helena Santos as its interim CFO until a suitable candidate can be appointed by the Company’s Board of Directors.
Nicholas Lavacca, who had served as the Company’s CFO since April 18, 2025, left the Company on May 19, 2025 to pursue other opportunities.
Reginald Averilla who had served as the Company’s CFO since April 11, 2022, left the Company to pursue other opportunities.
On April 1, 2025, Scientific Industries, Inc. (the “Company”), announced that it has appointed Nicholas Lavacca as its Chief Financial Officer (“CFO”).
On April 12, 2024, the Board of Directors (the “Board”) of Scientific Industries Inc. (the “Company”) appointed Michael Blechman (i) as a Class B Director of the Company, (ii) a member of the Board’s audit committee, (iii) a member of the Board’s compensation committee, and (iv) the Chair and member of the Company’s Nominating Committee.
Effective April 4, 2024, by mutual agreement between the Company and Mr. Marcus Frampton, Mr. Frampton who had been appointed a Director of the Company in March 2019, resigned from his position as a Class B Director of the Company’s Board of Directors.
On March 4, 2024, the Board of Directors (the “Board”) of the Scientific Industries Inc. (the “Company”) appointed John Nicols (i) as a Class C Director of the Company, (ii) a member of the Board’s audit committee and (iii) a member of the Board’s compensation committee.
Scientific Industries, Inc. issued a press release announcing the retirement of Joseph G. Cremonese, a member of the Company’s Class C Board of Directors and has therefore, resigned, from the Company’s Board of Directors, effective June 13, 2023.
Effective April 11, 2022, Scientific Industries, Inc. (the “Company”), hired Reginald Averilla as its Chief Financial Officer, replacing Helena R. Santos in that role
Effective April 11, 2022, Scientific Industries, Inc. (the “Company”), hired Reginald Averilla as its Chief Financial Officer, replacing Helena R. Santos in that role
Mr. Vogt resigned from his positions as a Class A Director of the Company’s Board of Directors, Chairman of the Company’s indirect wholly-owned subsidiary, Scientific Bioprocessing Inc. (”SBI”), and director of the Company’s wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc.
Mr. Vogt resigned from his positions as a Class A Director of the Company’s Board of Directors, Chairman of the Company’s indirect wholly-owned subsidiary, Scientific Bioprocessing Inc. (”SBI”), and director of the Company’s wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc.
Max materiality 0.90 · Median 0.50 · Most common event other_material